I think that Kakala is essentially right in seeing MSB as a $6 stock for the time being. I think the market has determined that nothing short of full FDA approval of CHF will shift the sp and that is going to be 2 or 3 years off and may never happen (even the positive analysts at Bell Potter estimate there's a 40% chance it will fail). Having said that, if it succeeds (60% chance) that's got to see a trippling of the sp. I don't think the upcoming Diabetes trial results will make any difference to the sp either.
I spent this week looking at what other stem cell companies are doing and a lot of them are reporting successes in the same indications at phase 1/2 level and their market capitalisation are a fraction of MSB so we can't expect positive Phase 2 announcements to shift the sp.
analysts, page-22
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |